Future Oncology Journal Issues Research Articles in Vol. 18, No. 32
December 24, 2022
December 24, 2022
LONDON, England, Dec. 24 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 18, No. 32 edition:
Clinical Trial Protocol:
* ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer
Preliminary Communication:
* Nomograms to predict progression of disease within 24 months in patients with localiz . . .
Clinical Trial Protocol:
* ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer
Preliminary Communication:
* Nomograms to predict progression of disease within 24 months in patients with localiz . . .